MARKET

CDNA

CDNA

Caredx
NASDAQ
18.53
-0.88
-4.53%
After Hours: 18.40 -0.13 -0.70% 19:05 12/05 EST
OPEN
19.26
PREV CLOSE
19.41
HIGH
19.35
LOW
18.37
VOLUME
639.06K
TURNOVER
--
52 WEEK HIGH
26.37
52 WEEK LOW
10.96
MARKET CAP
953.05M
P/E (TTM)
23.00
1D
5D
1M
3M
1Y
5Y
1D
CareDx Inc. Secretary and General Counsel Jeffrey Adam Novack Reports Sale of Common Shares
Reuters · 18h ago
Weekly Report: what happened at CDNA last week (1124-1128)?
Weekly Report · 5d ago
Craig-Hallum Keeps Their Buy Rating on CareDx (CDNA)
TipRanks · 11/25 14:25
CareDx Publishes Data On Third Manuscript From Surveillance HeartCare Outcomes Registry Shows Participants With Positive HeartCare Results Found At Higher Risk For Rejection-Related Complications
Benzinga · 11/24 21:10
CareDx SHORE Study Shows HeartCare Test Triples Risk Prediction for Heart Transplant Patients
Reuters · 11/24 21:06
SHORE Study Demonstrates HeartCare's Prognostic Value for Heart Transplant Recipients, Published in Journal of Heart and Lung Transplantation
Barchart · 11/24 15:05
Weekly Report: what happened at CDNA last week (1117-1121)?
Weekly Report · 11/24 09:20
Weekly Report: what happened at CDNA last week (1110-1114)?
Weekly Report · 11/17 09:20
More
About CDNA
CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the provider of genomics-based information for transplant patients. Its commercially available post-transplant testing services consist of AlloSure Kidney, a donor-derived cell-free DNA, or dd-cfDNA, solution for kidney transplant patients, AlloMap Heart, a gene expression profiling solution for heart transplant patients, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Its lab product portfolio includes QTYPE, Olerup SSP and SBT, AlloSeq Tx, AlloSeq HCT, and AlloSeq cfDNA. It also offers a diverse portfolio of digital solutions to transplant centers.

Webull offers CareDx Inc stock information, including NASDAQ: CDNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CDNA stock methods without spending real money on the virtual paper trading platform.